DESVENLAFAXINE SUCCNT ER 25 MG

DESVENLAFAXINE
$0.4402per EA

Strength

25 mg/1

NDC

72888017530

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DESVENLAFAXINE SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204028

On Market Since

1/31/2022

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price History

1W

0.0%

1M

-0.9%

3M

-3.5%

6M

-1.8%

1Y

-13.4%

3Y

N/A

5Y

N/A

All

+15.1%